Lantheus Holdings, Inc. (LNTH) Insider Trading Activity

NASDAQ$101.0997+0.3 (0.30%)
Market Cap
$6.58B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
633 of 849
Rank in Industry
35 of 48

LNTH Insider Trading Activity

LNTH Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio features several key products: DEFINITY, a microbubble ultrasound contrast agent for cardiac evaluations; TechneLite, a technetium …

Insider Activity of Lantheus Holdings, Inc.

Over the last 12 months, insiders at Lantheus Holdings, Inc. have bought $0 and sold $0 worth of Lantheus Holdings, Inc. stock.

On average, over the past 5 years, insiders at Lantheus Holdings, Inc. have bought $0 and sold $113.8M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $18,600 was made by Maeusli Heinz Christoph (director) on 2021‑03‑05.

List of Insider Buy and Sell Transactions, Lantheus Holdings, Inc.

2025-08-20SalePATEL RAJIV AMember of a Group Owning 10%
3.37M
4.9498%
$56.15
$188.94M
+30.19%
2025-08-20SaleFARALLON PARTNERS L L C/CAMember of a Group Owning 10%
3.37M
4.9498%
$56.15
$188.94M
+30.19%
2025-08-19SalePATEL RAJIV AMember of a Group Owning 10%
41,000
0.0605%
$55.34
$2.27M
+32.48%
2025-08-19SaleFARALLON PARTNERS L L C/CAMember of a Group Owning 10%
41,000
0.0605%
$55.34
$2.27M
+32.48%
2025-08-13SaleBlanchfield PaulPresident
3,060
0.0045%
$53.57
$163,924
+28.98%
2025-06-13SaleNiedzwiecki DanielSee Remarks
6,000
0.0088%
$78.74
$472,440
-12.85%
2025-06-09SaleMarshall Robert J. Jr.CFO and Treasurer
39,773
0.0573%
$83.00
$3.3M
-18.47%
2025-06-09SaleMcHugh Juliedirector
5,192
0.0074%
$81.62
$423,771
-18.47%
2025-06-05SaleBlanchfield PaulPresident
6,599
0.0095%
$79.65
$525,610
-15.54%
2025-06-05SaleNiedzwiecki DanielSee Remarks
6,000
0.0086%
$79.65
$477,900
-15.54%
2025-06-02SaleHeino Mary Annedirector
26,066
0.0375%
$76.83
$2M
-12.03%
2025-03-17SaleMarshall Robert J. Jr.CFO and Treasurer
10,000
0.0143%
$100.52
$1.01M
-33.97%
2025-03-13SaleHeino Mary Annedirector
2
<0.0001%
$100.13
$200
-31.66%
2025-03-05SaleBlanchfield PaulPresident
2,084
0.003%
$98.00
$204,232
-32.47%
2025-03-03SaleHeino Mary Annedirector
53,107
0.0769%
$94.35
$5.01M
-28.47%
2025-01-15SaleThrall James Hdirector
1,000
0.0015%
$94.76
$94,760
-21.53%
2024-11-15SaleMarshall Robert J. Jr.CFO and Treasurer
10,000
0.0143%
$81.20
$812,000
+5.09%
2024-11-14SaleBlanchfield PaulPresident
2,000
0.0028%
$79.65
$159,300
-0.24%
2024-11-08SaleHeino Mary Annedirector
11,487
0.0167%
$87.16
$1M
-7.61%
2024-08-21SaleThrall James Hdirector
1,000
0.0014%
$98.52
$98,520
-9.57%
Total: 296

Insider Historical Profitability

41.74%
Maeusli Heinz Christophdirector
23340
0.0357%
$2.35M81
+41.74%

Historical Insider Profitability vs. Competitors

$1,279,728,023
131
10.76%
$3.05B
$25,613,591
65
-3.30%
$12.27B
$14,599,168
59
12.79%
$1.66B
$102,709,455
46
30.55%
$1.45B
$73,762,556
45
-9.99%
$2.17B

LNTH Institutional Investors: Active Positions

Increased Positions188+33.16%11M+14.7%
Decreased Positions256-45.15%13M-17.91%
New Positions72New4MNew
Sold Out Positions99Sold Out3MSold Out
Total Postitions499-11.99%69M-3.21%

LNTH Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Blackrock, Inc.$556,037.0012.52%8.27M-267,690-3.14%2025-09-30
Vanguard Group Inc$467,689.0010.53%6.95M+115,338+1.69%2025-09-30
Janus Henderson Group Plc$449,682.0010.13%6.68M-254,247-3.66%2025-09-30
Fmr Llc$282,465.006.36%4.2M-820,140-16.34%2025-09-30
Morgan Stanley$260,883.005.88%3.88M+3M+423.5%2025-09-30
Farallon Capital Management Llc$233,913.005.27%3.48M-3M-48.27%2025-09-30
State Street Corp$167,975.003.78%2.5M-61,593-2.41%2025-09-30
Geode Capital Management, Llc$118,025.002.66%1.75M-22,431-1.26%2025-09-30
Dimensional Fund Advisors Lp$92,233.002.08%1.37M-12,042-0.87%2025-09-30
Reinhart Partners, Llc.$90,664.002.04%1.35M-55,903-3.98%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.